Publicaciones (50) Publicaciones en las que ha participado algún/a investigador/a

2016

  1. A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project

    International Journal of Neuropsychopharmacology, Vol. 19, Núm. 4

  2. A longitudinal study on anxiety, depressive and adjustment disorder, suicide ideation and symptoms of emotional distress in patients with cancer undergoing radiotherapy

    Journal of Psychosomatic Research, Vol. 87, pp. 14-21

  3. A quest for truth or solidarity? A third way ahead for psychoanalysis

    International Forum of Psychoanalysis, Vol. 25, Núm. 3, pp. 191-197

  4. Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients

    Journal of Clinical Psychopharmacology, Vol. 36, Núm. 4, pp. 355-371

  5. Age at first episode modulates diagnosis-related structural brain abnormalities in psychosis

    Schizophrenia Bulletin, Vol. 42, Núm. 2, pp. 344-357

  6. Amenazas en docencia e investigación: la Facultad de Medicina de la Universidad del País Vasco

    De la cuna al asilo: ¿cuál es el futuro de la salud mental en Europa? (Servicio de Publicaciones = Argitalpen Zerbitzua), pp. 279-295

  7. Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders

    European Psychiatry, Vol. 38, pp. 61-69

  8. BDNF and NGF Signalling in Early Phases of Psychosis: Relationship with Inflammation and Response to Antipsychotics after 1 Year

    Schizophrenia Bulletin, Vol. 42, Núm. 1, pp. 142-151

  9. COMT haplotypes, catecholamine metabolites in plasma and clinical response in schizophrenic and bipolar patients

    Pharmacogenomics, Vol. 17, Núm. 8, pp. 837-851

  10. Cognition and psychopathology in first-episode psychosis: Are they related to inflammation?

    Psychological Medicine, Vol. 46, Núm. 10, pp. 2133-2144

  11. Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: Study protocol for a randomized controlled trial

    Trials, Vol. 17, Núm. 1

  12. Cognitive reserve in bipolar disorder: Relation to cognition, psychosocial functioning and quality of life

    Acta Psychiatrica Scandinavica, Vol. 133, Núm. 5, pp. 386-398

  13. Colaboración atención primaria-salud mental en la asistencia a pacientes con depresión: evaluación de una experiencia piloto

    Atencion Primaria, Vol. 48, Núm. 6, pp. 356-365

  14. Combining social cognitive treatment, cognitive remediation, and functional skills training in schizophrenia: A randomized controlled trial

    npj Schizophrenia, Vol. 2

  15. Consenso español sobre los riesgos y detección de la hiperprolactinemia iatrogénica por antipsicóticos

    Revista de Psiquiatria y Salud Mental

  16. Cost-effectiveness analysis of sofosbuvir-simeprevir regimens for chronic hepatitis C genotype 1 patients with advanced fibrosis

    Medicina Clinica, Vol. 146, Núm. 2, pp. 61-64

  17. Depresión psicótica y catatonía crónica resistentes a terapia electroconvulsiva. Descripción de un caso de tratamiento con ketamina

    Psiquiatría biológica: Publicación oficial de la Sociedad Española de Psiquiatría Biológica, Vol. 23, Núm. 1, pp. 36-39

  18. Differences in facial emotion recognition between first episode psychosis, borderline personality disorder and healthy controls

    PLoS ONE, Vol. 11, Núm. 7

  19. Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis

    Journal of Psychiatric Research, Vol. 75, pp. 14-21

  20. Effects of functional remediation on neurocognitively impaired bipolar patients: Enhancement of verbal memory

    Psychological Medicine, Vol. 46, Núm. 2, pp. 291-301